4th Dec 2008 14:57
Standard Form TR-1Voting rights attached to shares- Article 12(1) of directive 2004/109/EC Financial instruments - Article 11(3) of the Commission Directive 2007/14/EC
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: United Drug Plc
2. Reason for the notification (please tick the appropriate box or boxes):
[✓ ] an acquisition or disposal of voting rights
[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
[ ] an event changing the breakdown of voting rights
3. Full name of person(s) subject to the notification obligation: FMR LLC and FIL Limited and their direct subsidiaries
4. Full name of shareholder(s) (if different from 3.):
5. Date of the transaction and date on which the threshold is crossed or reached: 02 December 2008
6. Date on which issuer notified; 03 December 2008
7. Threshold(s) that is/are crossed or reached: 8%
8. Notified details:
|
A) Voting rights attached to shares |
|||||||
|
Class/type of shares (if possible using the ISIN CODE) |
Situation previous to the Triggering transaction |
Resulting situation after the triggering transaction |
|||||
|
Number of Shares |
Number of Voting rights |
Number of shares |
Number of voting rights |
% of voting rights |
|||
|
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||
|
IE0033024807 |
18,493,607 |
18,493,607 |
18,679,407 |
18,679,407 |
8.03% |
||
|
SUBTOTAL A (based on aggregate voting rights) |
18,493,607 |
18,493,607 |
18,679,407 |
18,679,407 |
8.03% |
||
|
B) Financial Instruments |
||||
|
Resulting situation after the triggering transaction |
||||
|
Type of financial instrument |
Expiration Date |
Exercise/Conversion Period/ Date |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
|
SUBTOTAL B (in relation to all expiration dates) |
||||
|
Total (A+B) |
number of voting rights |
% of voting rights |
|
18,679,407 |
18,679,407 |
8.03% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
10. In case of proxy voting: FMR LLC and FIL Limited will acquire to hold 185,800 voting rights as of 02 December 2008.
11. Additional information:
c) Additional information
|
Fidelity |
|
|
|
|
|
|
|
|
|
Issuer name: |
United Drug Plc |
|
|
|
|
|
|
|
|
Current ownership percentage: |
8.03% |
|
|
|
|
|
|
|
|
Total shares held: |
18,679,407 |
|
|
|
|
|
|
|
|
Issued share capital: |
232,521,191 |
|
|
|
|
SHARES HELD |
NOMINEE |
MANAGEMENT COMPANY |
|
FIL Limited (FIL) is the parent holding company for various direct and indirect subsidiaries, including FIL Fund Management Limited (FFML), FIL Investment Services Ltd (FISL), FIL Gestion (FIGEST), FIL Investments Advisory (Korea) Limited (FIAKL), FIL Investments Management (Hong Kong) Limited (FIMHK), FIL Pension Management (FPM), FIL Investments Japan (FIJ) and FIL Investments International (FII), investment managers for various non-US investment companies and institutional clients. FMR LLC is the parent holding company of Fidelity Management & Research Company (FMRCO), investment manager for US mutual funds, and Fidelity Management Trust Company (FMTC) and Pyramis Global Advisors Trust Company (PGATC), a US state chartered bank which acts as a trustee or investment manager of various pension and trust accounts and Pyramis Global Advisors LLC (PGALLC). |
3,069,331 |
BROWN BROTHERS HARRIMAN AND CO |
FMRCO |
|
14,811,192 |
STATE STREET BANK AND TR CO |
FMRCO |
|
|
501,484 |
BROWN BROS HARRIMAN LTD LUX |
FIL |
|
|
111,600 |
CIBC MELLON TRUST © |
FCL |
|
|
185,800 |
BROWN BROTHERS HARRIMN LTD LUX © |
FIL |
|
Related Shares:
UDG.L